Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumiracoxib vs Indomethacin in Acute Gout
NCT00170781Phase 4Completed
- Sponsor
- Novartis
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of lumiracoxib in acute gouty arthritis (2 arms), sponsored by Novartis. Primary endpoint: Pain intensity in the study joint over days 2 to 5 approximately 4h after the first daily dose. Started Jun 2005; status: completed.
02
Drugs
lumiracoxib
03
Conditions
acute gouty arthritis
Beyond the preview
Go deeper on NCT00170781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170781.